Health Canada has approved Invokana® (canagliflozin) as an adjunct to diet, exercise, and standard-of-care therapy, to reduce the risk of end-stage …

The U.S. Food and Drug Administration (FDA) has approved Novo Nordisk’s Fiasp® (insulin aspart injection) 100 u/mL for use as a new mealtime …

Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) has expanded the label for Fiasp® (insulin aspart injection) 100 u/mL to …

The U.S. Food and Drug Administration (FDA) has approved Novo Nordisk’s new drug, Rybelsus® (semaglutide) tablets for adults with Type 2 …

Xeris Pharmaceuticals, Inc. announced today that it has received regulatory approval from the U.S. Food and Drug Administration (FDA) for …

AstraZeneca announced this week positive results from a landmark trial which showed that its diabetes drug, Farxiga reduced cardiovascular instances, …

Glenmark Pharmaceuticals Ltd. announced it has received regulatory approval to market a combination of a novel drug, Remogliflozinc, and Metformin …

Patients in Australia with diabetes-induced eye disease now have a new treatment option. The Australian Therapeutic Goods Administration (TGS) has …

The U.S. Food and Drug Administration (FDA) has approved Eli Lilly and Company’s BAQSIMI™ (glucagon) nasal powder 3 mg for the treatment …

AstraZeneca announced yesterday that the U.S. Food and Drug Administration (FDA) did not approve its diabetes treatment, Farxiga, for use as a …